Page last updated: 2024-09-03

astragaloside a and Obesity

astragaloside a has been researched along with Obesity in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Li, Z; Liu, Y; Luo, P; Wu, J; Yang, W; Yang, Y1
Bai, YY; Huang, F; Shi, HL; Wang, GR; Wang, XT; Wu, H; Wu, XJ; Yang, L; Yuan, JF1
Bi, Y; Jiang, P; Li, X; Ma, D; Wang, X; Wang, Y; Yang, J1
Gao, Y; Hu, ZB; Huang, F; Lan, YY; Qin, LY; Shi, HL; Wu, H; Wu, XJ; Zhang, BB1

Other Studies

4 other study(ies) available for astragaloside a and Obesity

ArticleYear
The Astragaloside IV Derivative LS-102 Ameliorates Obesity-Related Nephropathy.
    Drug design, development and therapy, 2022, Volume: 16

    Topics: Animals; Benzoxazoles; Diabetic Nephropathies; Mice; Obesity; Saponins; Triazines; Triterpenes

2022
Astragaloside IV ameliorates metabolic disorder in db/db obese mice as a PPARĪ³ antagonist.
    Journal of Asian natural products research, 2023, Volume: 25, Issue:5

    Topics: 3T3-L1 Cells; Animals; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; PPAR gamma; RNA, Messenger

2023
Astragaloside IV Prevents Obesity-Associated Hypertension by Improving Pro-Inflammatory Reaction and Leptin Resistance.
    Molecules and cells, 2018, Mar-31, Volume: 41, Issue:3

    Topics: Animals; Hypertension; Inflammation; Leptin; Male; Obesity; Rats; Rats, Wistar; Saponins; Triterpenes

2018
Astragaloside IV improves lipid metabolism in obese mice by alleviation of leptin resistance and regulation of thermogenic network.
    Scientific reports, 2016, 07-22, Volume: 6

    Topics: Adipose Tissue; Animals; Body Weight; Cell Line; Diet, High-Fat; Gene Expression; Leptin; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Receptors, Leptin; Saponins; Thermogenesis; Triglycerides; Triterpenes; Weight Gain

2016